Scarica l'app Stockscreener
0.83
1.10%
0.009
Dopo l'orario di chiusura:
.83
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.821
Aprire:
$0.8184
Volume 24 ore:
395.69K
Relative Volume:
0.36
Capitalizzazione di mercato:
$980.15K
Reddito:
$9.00M
Utile/perdita netta:
$-7.21M
Rapporto P/E:
-1.5091
EPS:
-0.55
Flusso di cassa netto:
$-7.59M
1 W Prestazione:
-6.53%
1M Prestazione:
-27.83%
6M Prestazione:
-91.12%
1 anno Prestazione:
-99.52%
Intervallo 1D:
$0.78
$0.84
Intervallo di 1 settimana:
$0.78
$0.8899
Portata 52W:
$0.723
$177.00
Applied Dna Sciences Inc Stock (APDN) Company Profile
Nome
Applied Dna Sciences Inc
Settore
Industria
Telefono
631-240-8800
Indirizzo
50 HEALTH SCIENCES DRIVE, STONY BROOK, NY
Confronta APDN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
APDN
Applied Dna Sciences Inc
|
0.83 | 980.15K | 9.00M | -7.21M | -7.59M | -0.55 |
|
TMO
Thermo Fisher Scientific Inc
|
432.59 | 159.40B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
200.83 | 141.27B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
509.53 | 38.21B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
115.55 | 30.90B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
156.13 | 26.35B | 15.50B | 1.33B | 2.16B | 7.34 |
Applied Dna Sciences Inc Stock (APDN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-02-12 | Iniziato | ROTH Capital | Buy |
| 2021-01-14 | Reiterato | H.C. Wainwright | Buy |
| 2020-12-18 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-20 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-02 | Iniziato | H.C. Wainwright | Buy |
| 2016-11-14 | Reiterato | Maxim Group | Buy |
| 2016-05-13 | Reiterato | Maxim Group | Buy |
| 2015-10-08 | Reiterato | Maxim Group | Buy |
| 2015-05-26 | Iniziato | The Benchmark Company | Speculative Buy |
| 2015-02-10 | Reiterato | Maxim Group | Buy |
| 2015-01-13 | Iniziato | Maxim Group | Buy |
Mostra tutto
Applied Dna Sciences Inc Borsa (APDN) Ultime notizie
Applied Dna Sciences Inc (APDN)’s Day in Review: Closing at 0.85, Down by -2.41 - DWinneX
Applied DNA Sciences Inc expected to post a loss of $3.00 a shareEarnings Preview - TradingView
Geode Capital Management LLC Grows Holdings in Applied DNA Sciences, Inc. (NASDAQ:APDN) - Defense World
Applied Dna Sciences Inc (APDN) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com
Applied DNA Sciences (APDN) to Release Quarterly Earnings on Friday - Defense World
Investing in Applied Dna Sciences Inc (APDN) Is Getting More Attractive - knoxdaily.com
Ratios Revealed: Decoding Applied Dna Sciences Inc (APDN)’s Financial Health - DWinneX
Applied DNA Sciences, Inc. (NASDAQ:APDN) Short Interest Update - Defense World
Financial Analysis: Applied Dna Sciences Inc (APDN)’s Ratios Unveil Key Insights - DWinneX
Press Release Distribution & PR Platform - ACCESS Newswire
Analysts Say Applied Dna Sciences Inc (NASDAQ:APDN) Can Really Get To 1.5 In 12 Months - Marketing Sentinel
Applied Dna Sciences Inc [APDN] Investment Appeal on the Rise - knoxdaily.com
Market Highlights: Applied Dna Sciences Inc (APDN) Ends on a High Note at 0.90 - DWinneX
Applied Dna Sciences Inc (APDN) Stock: A 52-Week Tale of Drops and Gains - investchronicle.com
APDN’s earnings estimates: Are they on track to meet expectations? - uspostnews.com
Applied DNA Sciences (APDN) Enhances U.S. Supply Chain for Genetic Medicine Platforms | APDN Stock News - GuruFocus
Applied DNA secures U.S. supply chain for key materials By Investing.com - Investing.com Canada
Applied DNA Sciences (APDN) Enhances U.S. Supply Chain for Genet - GuruFocus
Applied DNA secures U.S. supply chain for key materials - Investing.com
Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA | APDN Stock News - GuruFocus
Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA - The Joplin Globe
US Biotech Leader LineaRx Transforms DNA Manufacturing with Major Domestic Supply Chain Shift - Stock Titan
APDN stock plunges to 52-week low at $0.89 amid market challenges By Investing.com - Investing.com South Africa
APDN stock plunges to 52-week low at $0.89 amid market challenges - Investing.com Canada
Applied DNA regains compliance with Nasdaq minimum bid price rule - MSN
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Applied DNA regains Nasdaq compliance with bid price By Investing.com - Investing.com South Africa
Applied DNA Sciences Regains Nasdaq Compliance on Minimum Bid Price Rule - MarketScreener
Applied DNA Sciences regains Nasdaq compliance with stock price By Investing.com - Investing.com South Africa
Applied DNA regains Nasdaq compliance with bid price - Investing.com
Applied DNA Sciences regains Nasdaq compliance with stock price - Investing.com
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement - Weatherford Democrat
Applied DNA Overcomes Delisting Threat: Successfully Maintains Nasdaq Standards - Stock Titan
APDN stock plunges to 52-week low at $1.14 amid steep decline - Investing.com Australia
APDN stock plunges to 52-week low at $1.14 amid steep decline By Investing.com - Investing.com South Africa
Applied DNA sets May 22 for virtual shareholder meeting By Investing.com - Investing.com India
Applied DNA sets May 22 for virtual shareholder meeting - Investing.com
Growth or Bubble? APDN’s Unexpected Surge - timothysykes.com
Why Applied DNA Sciences (APDN) Stock Is Rising - Benzinga
Applied DNA refines pharmacogenomics strategy By Investing.com - Investing.com Australia
Applied DNA refines pharmacogenomics strategy - Investing.com
Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement - ACCESS Newswire
Critical FDA Safety Alert Powers Applied DNA's New Cancer Drug Testing Solution - Stock Titan
APDN stock plunges to 52-week low at $1.63 amid steep decline - Investing.com Canada
Applied Dna Sciences Inc Azioni (APDN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.60%
2.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):